Urologists, of course: “Some doctors rejected the recommendation, saying it smacked of ageism and cost control by insurers. ‘It sounds like a regulation promulgated by an HMO’ to save money.”
Prostate cancer screening leads to more testing like prostate biopsies and potentially unnecessary treatment and surgery.
Cutting back on screening will affect the revenue of urologists.
Related posts:
- Prostate cancer screening and the PSA test
- Prostate cancer screening in men over 75
- Should prostate cancer screening stop after the age of 75?
- Should I get a PSA test for prostate cancer? A new study shows that screening for prostate cancer doesn’t necessarily save lives
- Prostate cancer screening in blacks, and the lack of balanced information
- How screening for prostate cancer can be a gamble, and why either screening or not has consequences
- Prostate surgery
KevinMD.com on Facebook
{ 2 comments }
“Cutting back on screening will affect the revenue of urologists.”
The proper phrasing, of course, is: “Cutting back on screening will affect the revenue stream of urologists.”
First of all it is a recommendation, not a mandate. The comment by the LA urologist may have been taken out of context. A 75 year old man in good health whose father is still alive may benefit from a biopsy after a proper informed consent discussion. A 50 year old man with Child’s B cirrrhosis, on the other hand, would probably not benefit from the screening. Medicine is more complex than a sound bite. But thanks for the post.
Comments on this entry are closed.